Surman A J, Doggrell S A
Department of Pharmacology, School of Medicine, University of Auckland, New Zealand.
J Cardiovasc Pharmacol. 1993 Jan;21(1):35-9. doi: 10.1097/00005344-199301000-00006.
We studied the effects of alprenolol and bromoacetylalprenololmenthane (BAAM) on rat left atria. Alprenolol and BAAM at 10(-7), 3 x 10(-7), and 10(-6) M inhibited the cardiac stimulation response slightly, which is indicative of membrane-stabilizing activity independent of beta-adrenoceptor blockade. This membrane-stabilizing activity was readily reversible. Alprenolol and BAAM also caused surmountable antagonism of isoprenaline responses, and this beta 1-adrenoceptor antagonism was slowly reversible. Inhibition of the isoprenaline responses with alprenolol and BAAM at 10(-6) M was at equilibrium after 60 min, which is indicative of reversible antagonism. We conclude that alprenolol and BAAM are competitive slowly reversible beta 1-adrenoceptor antagonists on rat left atria.
我们研究了阿普洛尔和溴乙酰阿普洛尔薄荷烷(BAAM)对大鼠左心房的影响。阿普洛尔和BAAM在10⁻⁷、3×10⁻⁷和10⁻⁶ M浓度下对心脏刺激反应有轻微抑制作用,这表明其具有与β-肾上腺素受体阻断无关的膜稳定活性。这种膜稳定活性易于逆转。阿普洛尔和BAAM还引起了对异丙肾上腺素反应的可克服性拮抗作用,且这种β₁-肾上腺素受体拮抗作用逆转缓慢。在10⁻⁶ M浓度下,阿普洛尔和BAAM对异丙肾上腺素反应的抑制作用在60分钟后达到平衡,这表明是可逆性拮抗作用。我们得出结论,阿普洛尔和BAAM是大鼠左心房上具有竞争性且逆转缓慢的β₁-肾上腺素受体拮抗剂。